Screening of siRNA Nanoparticles for Delivery to Airway Epithelial Cells Using High Content Analysis

Hibbitts, Alan; Lieggi, Nora; McCabe, Olive; Thomas, Warren; Barlow, James; O'Brien, Fiona; Cryan, Sally-Ann

Screening of siRNA Nanoparticles for Delivery to Airway Epithelia.pdf (640.31 kB)

Screening of siRNA Nanoparticles for Delivery to Airway Epithelial Cells Using High Content Analysis

Version 2 2022-02-08, 12:22

Version 1 2019-11-22, 17:21

journal contribution

posted on 2019-11-22, 17:21 authored by Alan Hibbitts, Nora Lieggi, Olive McCabe, Warren Thomas, James Barlow, Fiona O'Brien, Sally-Ann Cryan

Background:

Delivery of siRNA to the lungs via inhalation offers a unique opportunity to develop novel methods of treating a range of poorly treated respiratory conditions. However progress has been greatly hindered by safety and delivery issues. This study developed a high-throughput method for screening novel nanotechnologies for pulmonary siRNA delivery

Methodology:

Following physico-chemical analysis, the ability of PEI-PEG/siRNA nanoparticles to facilitate siRNA delivery was determined using high content analysis (HCA) in Calu-3 cells. Results obtained from HCA were validated using confocal microscopy. Finally, cytotoxicity of the PEI-PEG/siRNA particles was analysed by HCA using the Cellomics® multiparamter cytotoxicity assay.

Conclusions:

PEI-PEG/siRNA nanoparticles facilitated increased siRNA uptake and luciferase knockdown in Calu-3 cells compared to PEI/siRNA.

History

Comments

This article is also availble at http://www.future-science.com/doi/abs/10.4155/tde.11.73

Published Citation

Hibbitts A, Lieggi N, McCabe O, Thomas W, Barlow J, O’Brien F, Cryan SA. Screening of siRNA Nanoparticles for Delivery to Airway Epithelial Cells Using High Content Analysis. Therapeutic Delivery. 2011;2(8):987-999.